MAY DENINA: Open Payments
NPI 1902309230 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 10 payments from 6 companies in 2025. Trend: 2023 $362 · 2024 $0 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $518 |
| Ipsen Biopharmaceuticals, Inc | 2 | $250 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $124 |
| Gilead Sciences, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $119 |
| Exact Sciences Corporation | 1 | $116 |
Products named: IQIRVO, RINVOQ, SKYRIZI, CREON, XIFAXAN, Vemlidy, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across NV — which companies pay providers there.
